Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and Acute Lymphoid Leukemia

staurosporine has been researched along with Acute Lymphoid Leukemia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Gautam, LN; Lang, W; Ling, T; Rivas, F1
Das, S; Feng, X; Jeffries, C; Lang, W; Ling, T; Maier, J; Rivas, F; Shelat, A1
Cai, Z; Chao, J; Chen, J; Chen, Y; Chen, Z; Deng, X; Dong, L; Gu, Z; Han, L; He, X; Huang, H; Leung, K; Li, W; Li, Y; Marcucci, G; Müschen, M; Ngo, VN; Nguyen, LXT; Prince, E; Qian, Z; Qin, H; Qin, X; Qing, Y; Shen, C; Sheng, Y; Shi, Y; Small, A; Su, R; Tan, B; Wang, K; Weng, H; Wu, D; Wu, X; Xiao, G; Xu, M; Xue, J; Zhang, B; Zhang, Z; Zhao, Z; Zhou, K1
Hayakawa, F; Hirano, D; Kiyoi, H; Odaira, K; Sakai, T; Tange, N; Terakura, S; Tsuzuki, S; Yamamoto, H; Yasuda, T1
Camós, M; Català, A; Caviedes-Cárdenas, L; Fernández-Calotti, P; Malatesta, R; Pastor-Anglada, M; Rives, S; Vega-García, N1
Armstrong, SA; Den Boer, ML; Fletcher, JA; Golub, TR; Griffin, JD; Kersey, JH; Korsmeyer, SJ; Kung, AL; Mabon, ME; Pieters, R; Sallan, SE; Silverman, LB; Stam, RW1
Clark, JJ; Cools, J; Fabbro, D; Furet, P; Gilliland, DG; Griffin, JD; Marynen, P; Mentens, N1
Zhang, GS1
Armstrong, SA; Beverloo, HB; de Lorenzo, P; den Boer, ML; Horstmann, M; Nollau, P; Pieters, R; Sallan, SE; Schneider, P; Stam, RW; Valsecchi, MG; van der Voort, E1
Chiaretti, S; Diverio, D; Foa, R; Guarini, A; Maggio, R; Porzia, A; Ritz, J; Tatarelli, C; Torelli, GF; Vitale, A1

Other Studies

10 other study(ies) available for staurosporine and Acute Lymphoid Leukemia

ArticleYear
Anti-proliferative evaluation of monoterpene derivatives against leukemia.
    European journal of medicinal chemistry, 2016, May-04, Volume: 113

    Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Monoterpenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Structure-Activity Relationship

2016
Novel vitexin-inspired scaffold against leukemia.
    European journal of medicinal chemistry, 2018, Feb-25, Volume: 146

    Topics: Apigenin; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Structure-Activity Relationship

2018
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia.
    Science translational medicine, 2023, 03-29, Volume: 15, Issue:689

    Topics: Animals; DNA-Binding Proteins; Mice; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Signal Transduction; Staurosporine

2023
Staurosporine and venetoclax induce the caspase-dependent proteolysis of MEF2D-fusion proteins and apoptosis in MEF2D-fusion (+) ALL cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 128

    Topics: Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Caspases; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Fusion; HEK293 Cells; Humans; MEF2 Transcription Factors; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteolysis; Signal Transduction; Staurosporine; Sulfonamides

2020
FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia.
    Oncotarget, 2016, Aug-02, Volume: 7, Issue:31

    Topics: Adolescent; Apoptosis; Biological Transport; Cell Line, Tumor; Child; Child, Preschool; Cytarabine; DNA Mutational Analysis; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Female; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Leukemic; Histone-Lysine N-Methyltransferase; Humans; Infant; Infant, Newborn; Male; Mutation; Myeloid-Lymphoid Leukemia Protein; Nucleoside Transport Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Staurosporine

2016
Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.
    Cancer cell, 2003, Volume: 3, Issue:2

    Topics: Animals; Annexin A5; Antineoplastic Agents; Child, Preschool; DNA-Binding Proteins; Female; fms-Like Tyrosine Kinase 3; Gene Expression; Histone-Lysine N-Methyltransferase; Humans; In Situ Hybridization, Fluorescence; Interleukin-3; Mice; Myeloid-Lymphoid Leukemia Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase C; Proto-Oncogene Proteins; Proto-Oncogenes; Receptor Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; Staurosporine; Transcription Factors; Transfection; Tumor Cells, Cultured

2003
Prediction of resistance to small molecule FLT3 inhibitors: implications for molecularly targeted therapy of acute leukemia.
    Cancer research, 2004, Sep-15, Volume: 64, Issue:18

    Topics: Acute Disease; Amino Acid Sequence; Animals; Drug Resistance, Neoplasm; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; Leukemia, Myeloid; Mice; Models, Molecular; Molecular Sequence Data; Point Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Structure, Tertiary; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Staurosporine; Structure-Activity Relationship

2004
[New targets for molecular therapy of acute leukemia: a "single-hit" or "multiple-hit" strategy against signaling pathway].
    Zhonghua yi xue za zhi, 2005, Feb-23, Volume: 85, Issue:7

    Topics: Acute Disease; Antineoplastic Agents; Carbazoles; Furans; Humans; Indoles; Leukemia; Leukemia, Myeloid, Acute; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein-Tyrosine Kinases; Quinolones; ras Proteins; Staurosporine

2005
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia.
    Blood, 2005, Oct-01, Volume: 106, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line, Tumor; DNA; DNA Mutational Analysis; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Gene Duplication; Gene Rearrangement; Humans; Immunoprecipitation; In Situ Hybridization, Fluorescence; Infant; Infant, Newborn; Ligands; Mutation; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; RNA; Sequence Analysis, DNA; Staurosporine; Tetrazolium Salts; Thiazoles

2005
FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemia.
    British journal of haematology, 2005, Volume: 130, Issue:1

    Topics: Adult; Blotting, Western; Case-Control Studies; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; DNA, Complementary; fms-Like Tyrosine Kinase 3; Humans; Membrane Proteins; Oligonucleotide Array Sequence Analysis; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase C; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; RNA, Messenger; Signal Transduction; Staurosporine; Translocation, Genetic

2005